- Supported exchanges /
- SHG /
- 688468.SHG
Chemclin Diagnostics Co. Ltd. A (688468 SHG) stock market data APIs
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. The company was founded in 2007 and is headquartered in Beijing, China.
Chemclin Diagnostics Co. Ltd. A Financial Data Overview
6.45 | |
6.52 | |
- | |
6.59 | |
6.4 | |
5.28-12.7008 | |
2 587 M | |
17.4324 | |
401 M | |
452 M | |
0.0869 | |
0.0193 | |
-0.003 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Chemclin Diagnostics Co. Ltd. A Fundamental Data is available in our Financial Data APIs
- Net Revenue 452 M
- EBITDA 171 M
- Earnings Per Share 0.37
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Chemclin Diagnostics Co. Ltd. A Earnings via APIs
- Latest Release 2023-03-31
- EPS/Forecast NaN
Get Chemclin Diagnostics Co. Ltd. A End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: